See also this year's filing and all EDGAR filings for this company.
PDF Report 0001797768_2022_Kinnate_Biopharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001797768, Kinnate Biopharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 258,690,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 956,000 |
| 3 | remainder_Assets | 107,218,000 |
| 4 | LiabilitiesCurrent | 12,387,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,945,000 |
| 9 | ResearchAndDevelopmentExpense | 67,166,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 348,000 |
| 13 | remainder_ComprehensiveNetIncome | -515,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 366,864,000 |
| 1 | Liabilities | 12,387,000 |
| 2 | Expenses | 90,111,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 354,477,000 |
| 5 | NetIncome | -89,763,000 |
| 6 | ComprehensiveNetIncome | -90,020,500 |
| 7 | BaseVar | 235,112,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.60 |
| 9 | EconomicCapitalRatio | 4.10 |